ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Episode 28 – Emerging treatment options for long-term prophylaxis in HAE"
Episode Synopsis
What are the available treatment options for long-term prophylaxis in HAE, and why are more options being investigated? Dr Thomas Buttgereit discusses the latest treatment advances, including mechanism of action, efficacy and safety, with guest Professor Timothy Craig.
For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/. Additional resources relating to the topics discussed in this episode can be found here: C1 inhibitor review; open label extension of APeX-2 study; VANGUARD phase 3 study; HELP OLE study; OASIS-HAE study; CRISPR in HAE.
For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/. Additional resources relating to the topics discussed in this episode can be found here: C1 inhibitor review; open label extension of APeX-2 study; VANGUARD phase 3 study; HELP OLE study; OASIS-HAE study; CRISPR in HAE.
More episodes of the podcast All Things Angioedema – Learning about angioedema with Dr. Thomas Buttgereit
COVID-19 & Angioedema: Insights from Italy
02/09/2025
HAE in Mexico: Challenges, Progress & Hope
08/07/2025
AI & Data Science in Angioedema Research
06/05/2025
Mortality in HAE: The Silent Threat
08/04/2025
In God we trust